← Back to Search
Design And Characterization Of Chitosan Nanoformulations For The Delivery Of Antifungal Agents
Natalia L. Calvo, S. Sreekumar, L. Svetaz, M. C. Lamas, B. Moerschbacher, D. Leonardi
Published 2019 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Among different Candida species triggering vaginal candidiasis, Candida albicans is the most predominant yeast. It is commonly treated using azole drugs such as Tioconazole (TIO) and Econazole (ECO). However, their low water solubility may affect their therapeutic efficiency. Therefore, the aim of this research was to produce a novel chitosan nanocapsule based delivery system comprising of TIO or ECO and to study their suitability in vaginal application. These systems were characterized by their physicochemical properties, encapsulation efficiency, in vitro release, storage stability, cytotoxicity, and in vitro biological activity. Both nanocapsules loaded with TIO (average hydrodynamic size of 146.8 ± 0.8 nm, zeta potential of +24.7 ± 1.1 mV) or ECO (average hydrodynamic size of 127.1 ± 1.5 nm, zeta potential of +33.0 ± 1.0 mV) showed excellent association efficiency (99% for TIO and 87% for ECO). The analysis of size, polydispersity index, and zeta potential of the systems at 4, 25, and 37 °C (over a period of two months) showed the stability of the systems. Finally, the developed nanosystems presented fungicidal activity against C. albicans at non-toxic concentrations (studied on model human skin cells). The results obtained from this study are the first step in the development of a pharmaceutical dosage form suitable for the treatment of vaginal candidiasis.
This paper references
Spray-dried powders improve the controlled release of antifungal tioconazole-loaded polymeric nanocapsules compared to with lyophilized products.
R. F. Ribeiro (2016)
A vaginal fluid simulant.
D. Owen (1999)
Novel drug delivery strategies for improving econazole antifungal action.
A. Firooz (2015)
Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.
N. Passerini (2009)
A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach
S. Vicente (2013)
Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis.
Natalia L. Calvo (2019)
Why Chitosan? From properties to perspective of mucosal drug delivery.
A. Kumar (2016)
Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents
C. Spampinato (2013)
Fractal kinetics in drug release from finite fractal matrices
K. Kosmidis (2003)
Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
C. Prego (2006)
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery
S. Deshkar (2019)
Chitosan in nanostructured thin films.
F. Pavinatto (2010)
Biodegradation of benzo[a]pyrene with immobilized laccase: Genotoxicity of the products in HaCat and A3 cells
Xiaoke Hu (2007)
Emulsion Stability and Testing
Analytical Profiles Of Drug Substances And Excipients
L. Jaeger (2016)
Chitosan based drug delivery systems
A. Piegat (2016)
P. Hoeprich (1995)
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)
Structural analysis of chitosan hydrogels containing polymeric nanocapsules.
R. V. Contri (2014)
On methods of expressing dissolution rate data
J. A. Goldsmith (1978)
Chitosan-coated dapsone-loaded lipid-core nanocapsules: Growth inhibition of clinical isolates, multidrug-resistant Staphylococcus aureus and Aspergillus ssp.
Rodrigo Cé (2016)
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
M. Lozano (2008)
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
F. Danhier (2015)
Design, Characterization, and In Vitro Evaluation of Antifungal Polymeric Films
D. Real (2012)
Advances in topical and systemic antifungals.
A. Zhang (2007)
Método de dilución en medio líquido. In Manual de Técnicas in vitro para la detección de compuestos antifúngicos
L Rodero (2007)
Método de dilución en medio líquido
L. Rodero (2007)
Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections
M. A. Alam (2008)
On the use of the Weibull function for the discernment of drug release mechanisms.
V. Papadopoulou (2006)
Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution
F. Langenbucher (1972)
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
Candida Infections of the Genitourinary Tract
J. Achkar (2010)
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
Y. Zhang (2010)
Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
A. Machado (2016)
Therapeutic applications of colloidal drug carriers.
An algorithm to determine the mechanism of drug distribution in lipid-core nanocapsule formulations
C. P. D. Oliveira (2013)
Chapter 15 Antifungal Chemotherapy
J. Heeres (1980)
Formation of New Glucomannan−Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins
M. Alonso-Sande (2006)
Nanocapsules: the weapons for novel drug delivery systems.
Pavankumar Kothamasu (2012)
Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
E. Schultze (2014)
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer.
D. Vergara (2012)
Lutein-loaded lipid-core nanocapsules: Physicochemical characterization and stability evaluation
A. Brum (2017)
A review on chitosan and its nanocomposites in drug delivery.
A. Ali (2018)
Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil.
E. Schultze (2017)
Antifungal Chemotherapy. In Annual Reports in Medicinal Chemistry
J. Heeres (1980)
Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition
Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
E. Cevher (2014)
Adaptations of Candida albicans for Growth in the Mammalian Intestinal Tract
A. Rosenbach (2010)
Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.
J. Pardeike (2010)
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations
D. Real (2018)
Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release
N. Iglesias (2019)
Model Selection and Multimodel Inference
S. Creel (2003)
Characterization of Different Functionalized Lipidic Nanocapsules as Potential Drug Carriers
Paola Sánchez-Moreno (2012)
This paper is referenced by
Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources
F. Sousa (2020)
Pharmaceutical care in the context of an Extension Project to care for patients with vaginal candidiasis with the strategy of carrying out antifungal resistance testing and community health prevention
M. L. Menz (2020)
Nanosystems against candidiasis: a review of studies performed over the last two decades
Victor Hugo Sousa Araujo (2020)
Development and in vitro evaluation of mucoadhesive gelatin films for the vaginal delivery of econazole.
Luisa Stella Dolci (2020)
Development of innovative delivery systems to counteract vaginal infections
Barbara Giordani (2020)